About this episode
Numinus Founder & CEO Payton Nyquvest sits down with me at SXSW in Austin to talk about the trajectory that his company Numinus has been on to position themselves as being on track to be the first profitable publicly traded psychedelics company. We talk about the Numinus approach to the psychedelics space, music as a tool for healing, the road map for the next few years in this space, and more.
Please consider rating & reviewing the podcast wherever you're listening.
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time Mycopreneur publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Mycopreneur
Lee Carroll: Ergothioneine in Support of Psychedelic Therapy
Mycopreneur
Adam Miezio: Psychedelics in the Epstein Files
Mycopreneur
Robert Gallery: Ibogaine For Athletes with Traumatic Brain Injuries
Mycopreneur
Melanie Tremblay: The Hidden Dangers of AI-Generated Mushroom Claims
Mycopreneur